Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Splenectomy is sometimes indicated for portal hypertension caused by cirrhosis, which is a risk for hepatic carcinogenesis. This study aimed to identify risk factors for hepatocellular carcinoma (HCC) development after splenectomy. Methods: This retrospective study included 65 patients who underwent splenectomy for portal hypertension between 2009 and 2017. Cox regression analyses were performed to identify factors related to HCC development after splenectomy. The predictive index for HCC development was constructed from the results of multivariate analysis, and 3 risk-dependent groups were defined. Discrimination among the groups was estimated using Kaplan-Meier curves and the log-rank test. Results: Post-splenectomy, 36.9% of patients developed HCC. In the univariate analysis, the etiology of cirrhosis (hepatitis C virus antibody, P =.005, and hepatitis B surface antigen, P =.008, referring to non-B and non-C patients, respectively), presence of HCC history (P

Cite

CITATION STYLE

APA

Honmyo, N., Kobayashi, T., Kuroda, S., Ide, K., Ohira, M., Tahara, H., … Ohdan, H. (2023). Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients. American Surgeon, 89(4), 769–777. https://doi.org/10.1177/00031348211041562

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free